Johns Hopkins University

Utthara Nayar, PhD

April 8, 2024

Utthara Nayar, PhDJohns Hopkins UniversityBaltimore, MD Estrogen receptor mutations as a novel biomarker for response to endocrine therapy in ovarian cancer Dr. Nayar is pursuing a fast track to the clinical testing of a new treatment for low-grade serous ovarian cancers (LGSOCs). Some LGSOCs develop mutations in the estrogen receptor (ER) molecule and stop responding […]

Read More

The Rivkin Center Joins OCRA

Starting April 1, 2025, the Rivkin Center’s ovarian cancer research funding, global symposium and fundraising activities will continue under the leadership of Ovarian Cancer Research Alliance (OCRA).

Melissa Saul